MBBC Shorts Unwind Ahead of Next Week's Results

Marathon Bancorp heads into its May 19 earnings call with short sellers backing away hard and the stock quietly building one of its best multi-week runs of the year.

The short-side retreat is the clearest story in the data. Short interest has fallen nearly 28% over the past week, dropping to roughly 0.31% of the free float — a level so low it barely registers as a bearish signal. What makes the move striking is the context: as recently as late April, short interest had surged to its one-month peak, with borrowing conditions tightening noticeably and availability at its tightest. That spike has since fully unwound. Borrow availability is now extremely loose at over 3,200% of short interest, meaning shares are in plentiful supply for anyone still looking to short. Cost to borrow, at 3.92%, has eased from a late-April high above 5% and drifted gently lower across the past month. The ORTEX short score has dropped from around 40.5 on April 30 — its recent high — to 30.1 today, a sharp fall that signals substantially reduced bearish conviction in the lending market.

The price action reflects that shift. MBBC gained 3.3% on the week and 14.2% on the month, closing at $15.13. That puts the stock up roughly 24% year-to-date. RSI14 of 57 is constructive without being overbought — there is no sign of froth in the technical picture. The micro-cap market cap of around $44 million means the stock can move meaningfully on thin volume, and the one-month appreciation is substantial enough to have likely forced some of the short covering now showing in the data.

Institutional ownership is a standout feature for a bank of this size. The top three holders together account for nearly 19% of shares, with AllianceBernstein adding 20,000 shares in Q4 2025 and Maltese Capital — a known community-bank activist — adding 10,000 shares over the same period. Vanguard reported a significant addition of over 57,000 shares as of March 31, 2026. That's a notably concentrated ownership structure for a sub-$50 million market cap lender, with specialist small-bank investors clearly interested. Insider data is stale beyond the 90-day window, so the most recent on-record trades — CEO Nicholas Zillges buying in November 2025 around $11 — provide context rather than a current signal.

Earnings history is modest in terms of reaction. The last four prints produced day-one moves of -1.8%, -1.4%, +1.9%, and -0.5%. The five-day windows were similarly contained, with the exception of a +5.6% move following the November 2025 release. None of these qualify as high-volatility events for the stock. Closest Nasdaq-listed peer CHMG slipped 0.8% on the week while MBBC advanced, a small but notable divergence among regional bank comparables.

With Q3 2026 results now scheduled for May 19, the key question is whether the recent short-covering wave reflects informed positioning ahead of the print — or simply a drift back to baseline in a thinly traded name.